CD4 and Alzheimer disease: Taken together, our data demonstrate that Hh signaling induces and maintains functional Treg populations in the skin, leading to upregulation and activation of TGF-β, thus identifying a mechanism by which Gli2 activity in CD4+ T cells can control skin-specific immune responses and inflammation and reduce chronic AD.